Acutus Medical, Inc. (NASDAQ:AFIB) Short Interest Down 14.2% in March

Acutus Medical, Inc. (NASDAQ:AFIB) was the recipient of a large decrease in short interest during the month of March. As of March 31st, there was short interest totalling 845,200 shares, a decrease of 14.2% from the March 15th total of 984,700 shares. Currently, 4.5% of the shares of the company are sold short. Based on an average daily trading volume, of 2,250,000 shares, the days-to-cover ratio is currently 0.4 days.

Acutus Medical Price Performance

Shares of AFIB opened at $0.17 on Tuesday. The company has a market cap of $5.08 million, a P/E ratio of -0.14 and a beta of 0.19. The stock has a fifty day moving average price of $0.19 and a 200 day moving average price of $0.29. The company has a debt-to-equity ratio of 1.10, a current ratio of 2.44 and a quick ratio of 2.22. Acutus Medical has a 12 month low of $0.16 and a 12 month high of $1.09.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently modified their holdings of AFIB. Bank of Montreal Can bought a new position in shares of Acutus Medical in the first quarter worth $34,000. Mirabella Financial Services LLP bought a new position in shares of Acutus Medical in the first quarter worth $48,000. Cerity Partners LLC bought a new position in shares of Acutus Medical in the first quarter worth $48,000. Schonfeld Strategic Advisors LLC lifted its holdings in shares of Acutus Medical by 1,065.1% in the first quarter. Schonfeld Strategic Advisors LLC now owns 170,100 shares of the company’s stock valued at $128,000 after buying an additional 155,500 shares during the period. Finally, AQR Capital Management LLC lifted its holdings in shares of Acutus Medical by 844.0% in the second quarter. AQR Capital Management LLC now owns 174,352 shares of the company’s stock valued at $195,000 after buying an additional 155,883 shares during the period. Institutional investors own 56.91% of the company’s stock.

Acutus Medical Company Profile

Acutus Medical, Inc, an arrhythmia management company, designs, manufactures, and markets various tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. Its product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact force ablation catheters, and mapping and imaging consoles and accessories, as well as supporting algorithms and software programs.